|
17 Sep 2025 |
HDFC Bank
|
Consensus Share Price Target
|
965.35 |
1138.36 |
- |
17.92 |
buy
|
|
|
|
|
21 Apr 2024
|
HDFC Bank
|
Motilal Oswal
|
965.35
|
1950.00
|
1531.30
(-36.96%)
|
Pre-Bonus/ Split |
Buy
|
|
|
HDFCB delivered a healthy quarter, with NIMs improving 4bp QoQ and the CD ratio declining 6% QoQ to 104%. PAT (adj. for one-offs) and NII both stood in line with our estimates.
|
|
21 Apr 2024
|
HDFC Bank
|
ICICI Securities Limited
|
965.35
|
1850.00
|
1531.30
(-36.96%)
|
Target met |
Buy
|
|
|
Apart from strong deposits growth and subdued loan growth, which were already communicated, key highlights from HDFC Bank’s (HDFCB) Q4FY24 results include: 1) sharp reduction in borrowing (down 10% QoQ); 2) 3–4bps QoQ rise in NIM
|
|
20 Apr 2024
|
HDFC Bank
|
Sharekhan
|
965.35
|
1900.00
|
1531.30
(-36.96%)
|
Target met |
Buy
|
|
|
HDFC Bank reported broadly in-line performance in Q4FY24. Numbers on a y-o-y numbers are not comparable as this is the third quarter reported after the merger. NII at Rs. 29,077 crore (up 2% q-o-q) was in line with expectations driven by stable NIM of 3.4% (marginally improved by 4 bps q-o-q) and net loan growth of 1.6% q-o-q.
|
|
04 Apr 2024
|
HDFC Bank
|
Sharekhan
|
965.35
|
1900.00
|
1549.55
(-37.70%)
|
Pre-Bonus/ Split |
Buy
|
|
|
|
|
16 Feb 2024
|
HDFC Bank
|
Ashika Research
|
965.35
|
1600.00
|
1419.90
(-32.01%)
|
Target met |
Buy
|
|
|
|
|
20 Jan 2024
|
HDFC Bank
|
ICICI Direct
|
965.35
|
1800.00
|
1478.85
(-34.72%)
|
Target met |
Buy
|
|
|
|
|
17 Jan 2024
|
HDFC Bank
|
Prabhudas Lilladhar
|
965.35
|
2000.00
|
1537.50
(-37.21%)
|
Pre-Bonus/ Split |
Buy
|
|
|
|
|
17 Jan 2024
|
HDFC Bank
|
BOB Capital Markets Ltd.
|
965.35
|
1896.00
|
1486.15
(-35.04%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Building Materials: Strong foundations HDFCB: Margin pressure dampens performance
|
|
17 Jan 2024
|
HDFC Bank
|
BP Wealth
|
965.35
|
|
1537.50
(-37.21%)
|
Pre-Bonus/ Split |
Results Update
|
|
|
|
|
17 Jan 2024
|
HDFC Bank
|
Axis Direct
|
965.35
|
1975.00
|
1537.50
(-37.21%)
|
Pre-Bonus/ Split |
Buy
|
|
|
Recommendation: We maintain our BUY recommendation on the stock.
|